SGHT Q3 2022 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+42.6% YoY

Gross Profit

$16M84.3% margin

Operating Income

-$22M-117.0% margin

Net Income

-$22M-119.0% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$225M

Total Liabilities

$52M

Stockholders' Equity

$173M

Cash & Equivalents

$200M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$13M	+42.6%
Gross Profit	$16M	$11M	+42.7%
Operating Income	-$22M	-$14M	-55.7%
Net Income	-$22M	-$17M	-29.5%

Revenue Segments

Surgical Glaucoma

$17M91%

Dry Eye

$2M9%